Marker Therapeutics Market Cap

Marker Therapeutics has a market cap or net worth of $41.47 million as of June 26, 2024. Its market cap has increased by 50.27% in one year.

Market Cap

41.47M

Enterprise Value

31.31M

1-Year Change

50.27%

Ranking

#4632

Market Cap Chart

Since November 8, 2016, Marker Therapeutics's market cap has decreased from $45.80M to $41.47M, a decrease of -9.45%. That is a compound annual growth rate of -1.29%.

Market Cap History

Date	Market Cap	% Change
Jun 25, 2024	41.40M	-1.43%
Jun 24, 2024	42.00M	9.09%
Jun 21, 2024	38.50M	-3.75%
Jun 20, 2024	40.00M	-2.91%
Jun 18, 2024	41.20M	-3.29%
Jun 17, 2024	42.60M	14.82%
Jun 14, 2024	37.10M	3.34%
Jun 13, 2024	35.90M	0.56%
Jun 12, 2024	35.70M	3.78%
Jun 11, 2024	34.40M	11.33%
Jun 10, 2024	30.90M	-
Jun 7, 2024	30.90M	4.04%
Jun 6, 2024	29.70M	-8.90%
Jun 5, 2024	32.60M	0.31%
Jun 4, 2024	32.50M	-9.47%
Jun 3, 2024	35.90M	4.06%
May 31, 2024	34.50M	-3.63%
May 30, 2024	35.80M	0.85%
May 29, 2024	35.50M	1.14%
May 28, 2024	35.10M	-4.88%
May 24, 2024	36.90M	1.65%
May 23, 2024	36.30M	3.42%
May 22, 2024	35.10M	-3.84%
May 21, 2024	36.50M	-2.67%
May 20, 2024	37.50M	1.35%

View and export this data all the way back to 2016. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Atara Biotherapeutics	40.36M
Augmedix	39.35M
IN8bio	39.22M
electroCore	39.13M
Matinas BioPharma Holdings	38.60M
Lexaria Bioscience	38.53M
Owlet	38.36M
OncoCyte	37.82M

Market Cap Rankings